Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “monotherapy”

4 pharma patents match "monotherapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "monotherapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “monotherapy” · 30,257 patents in full index Clear search

  1. US 10993956

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted

  2. US 10342815

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  3. US 8962593

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  4. US 8957047

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.